UPC_CoA_49/2026
- Guardant Health, Inc.
- Sophia Genetics SAS
- Sophia Genetics GmbH
- Sophia Genetics SRL
- Sophia Genetics SA
Track this case
Get an email when a new order or decision is published in UPC_CoA_49/2026.
Decisions and documents (2)
- 2026-11-05procedural
- Applicant:
- Guardant Health, Inc.
- Respondents:
- Sophia Genetics GmbH; Sophia Genetics SA; Sophia Genetics SAS; Sophia Genetics SRL
For the unsuccessful party to be able to comment on both the necessity and the proportionality of the costs for representation, the applicant for a cost decision should provide a sufficiently substantiated specification of the costs in view of the circumstances of the case, which would generally include breakdowns corresponding to each service provided in relation to the case, the date on which such service was provided, and the number of hours and rate billed for that specific service. Exceeding the ceiling does not as such entitle a party to reimbursement of the ceiling set by the Administrative Committee pursuant to R.152.2 RoP.
- 2026-04-17procedural
- Applicant:
- Guardant Health, Inc.
- Respondents:
- Sophia Genetics GmbH; Sophia Genetics SA; Sophia Genetics SAS; Sophia Genetics SRL
Application to leave to appeal a cost decision (RoP221). Document: Order on leave to appeal 49-2026 (R. 221 RoP).pdf. Case page: https://www.unifiedpatentcourt.org/en/node/183092
Weekly digest
A weekly email summarising new published decisions across European patent courts.